The developing landscape of diabetes treatment is experiencing a exciting shift, driven by innovative incretin-based therapies. Presently, semaglutide has gained considerable traction, but rival medications like https://blanchervjs238309.activoblog.com/52578354/the-future-of-diabetes-comparing-tirzepatide-semaglutide-retatrutide-and-cagrilintide